Moderna and US at odds over vaccine patent rights

Moderna and the National Institutes of Health are in a bitter dispute over who deserves credit for inventing the central component of the company’s powerful coronavirus vaccine, a conflict that has broad implications for the vaccine’s long-term distribution and billions of dollars in future profits.

from bdnews24.com - Home https://ift.tt/3Hacfng